Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Interactions Between Bictegravir, Tenofovir Alafenamide and Rifapentine in Healthy Adults
NCT04551573Phase 4Withdrawn
- Sponsor
- Yale University
- Start
- May 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rifapentine in Tuberculosis (TB), human immunodeficiency virus infection (HIV), sponsored by Yale University. Planned start May 2021; status: withdrawn.
02
Drugs
rifapentine
03
Conditions
Tuberculosis (TB)human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04551573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04551573.